Home » Clinical Trials » Medical Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology
Disease Category: Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
Trial Information
Bipolar Disorder Research Study
Summit Research Network Announces
An Investigational Drug Study for People with Bipolar I Disorder
Will the study drug or a placebo added to a mood stabilizer reduce the symptoms of depression in people with Bipolar I Disorder?
About the Protocol:
The purpose of this clinical research study is to evaluate the safety and effectiveness of the study drug in reducing the symptoms of depression in people with bipolar I, as compared to a placebo (an inactive substance that looks like the study drug but has no effect on health), when taken twice a day for 6 weeks, in addition to a mood stabilizer.
Are you eligible?
You may be eligible for this clinical study if you:
- Are at least 18 years old
- Have been diagnosed with bipolar I and are experiencing a current depressed episode
- Have a history of at least 1 bipolar manic or mixed episode
About participation in this clinical research study:
If you are eligible and you wish to take part in this clinical study, your participation may last up to 12 weeks. You will have screening tests over the course of 1 week to 42 days. The tests will include a study-related physical exam, ECG, blood and urine samples, and a psychiatric interview. During the screening period, you will receive a mood stabilizer at no cost, and the study staff will contact you at least once a week by phone. If you have been taking any combination of lithium, valproate, or lamotrigine, you will continue to take one of these mood stabilizers. If you have not been taking any of these, you will be assigned to receive either lithium or valproate.
206.292.CARE (2273)
www.SummitResearchCares.com
Summit Research Network (Seattle) LLC
901 Boren Avenue, Suite 1800
Seattle WA 98104
Phone: 206-292-2273
EMail: shannonk@summitnetwork.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
